Polypid LTD Schedule 13G passive stakes

An amended Schedule 13G filing reveals that Rodney Hodges and associated entities collectively hold a substantial 13.4% stake in PolyPid Ltd., including exercisable warrants.

Rosalind Advisors Inc. and related entities have filed a Schedule 13G, reporting a 9.9% beneficial ownership in PolyPid Ltd., with significant holdings subject to blocker provisions.

Rosalind Advisors Inc. and related entities report beneficial ownership of 9.9% of PolyPid Ltd. common stock, primarily through warrants.

Aurum Ventures M.K.I. Ltd. has increased its beneficial ownership in Polypid Ltd. to 24.4% through the exercise of warrants.

Rosalind Advisors and affiliated entities report a 9.9% beneficial ownership in PolyPid Ltd., including shares and warrants, subject to a 9.99% ownership blocker.

AIGH Capital Management LLC and Orin Hirschman have reported a 9.8% beneficial ownership stake in PolyPid Ltd. as of December 31, 2025.

Rosalind Advisors and affiliated entities report a 9.9% beneficial ownership stake in PolyPid Ltd., including warrants subject to a 9.99% blocker provision.

Aurum Ventures M.K.I. Ltd. and Morris Kahn have reported a combined beneficial ownership of 28.1% in PolyPid Ltd., including shares from exercisable warrants.

Rosalind Advisors and affiliated entities report a 9.9% beneficial ownership stake in PolyPid Ltd., including common shares and warrants.

AIGH Capital Management LLC and Orin Hirschman have disclosed a 7.7% beneficial ownership stake in PolyPid Ltd., totaling 1,194,108 ordinary shares.

Aharon Lukach has filed an amended Schedule 13G, disclosing a beneficial ownership of 5.2% of PolyPid Ltd.'s ordinary shares as of March 31, 2025.

Yehuda Nir has filed an amended Schedule 13G, disclosing beneficial ownership of 10.1% of PolyPid Ltd.'s ordinary shares as of March 31, 2025.

Aurum Ventures M.K.I. Ltd. and Morris Kahn have updated their beneficial ownership in PolyPid Ltd., reporting a combined 19.8% stake as of December 31, 2024.

Rosalind Advisors, Inc. and its affiliates have disclosed a 9.9% passive beneficial ownership stake in PolyPid Ltd., primarily through Rosalind Master Fund L.P., with a significant portion of potential shares from warrants currently unexercisable due to a blocker provision.

A group of investors, including Rodney Hodges and affiliated entities, have filed an amended Schedule 13G, reaffirming their collective beneficial ownership of up to 19.9% of PolyPid Ltd.'s Ordinary Shares, including exercisable warrants.

Rosalind Advisors, Inc., along with its affiliates Steven Salamon, Gilad Aharon, and Rosalind Master Fund L.P., have disclosed a combined beneficial ownership of 9.9% in PolyPid Ltd., totaling 4,085,588 common shares, as detailed in an amended Schedule 13G filing.